FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to compound, represented by the following formula
,
or its pharmaceutically acceptable salt. In claimed formula each symbol has values, determined in formula of invention. Versions of formula [I] compound and particular compounds are also objects of invention. In addition, invention relates to pharmaceutical composition, ITK inhibitor and means for treatment or prevention of inflammatory diseases, allergic diseases, autoimmune diseases, transplant rejection and other diseases and methods of treating said diseases.
EFFECT: claimed compounds inhibit induced T-cellular kinase (ITK).
32 cl, 86 tbl, 387 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRIDIN DERIVATIVES AS DIPEPTIDYL PEPTIDASE IV INHIBITORS | 2004 |
|
RU2353617C2 |
| NEW HYDROXAMIC ACID DERIVATIVE | 2011 |
|
RU2575129C2 |
| N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS EFFECTIVE AS MONOAMINE REUPTAKE INHIBITORS | 2006 |
|
RU2574406C2 |
| NEW OCTAHYDROTHIENOQUINOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING DERIVATIVE, AND USING THEM | 2012 |
|
RU2573399C2 |
| NOVEL BICYCLIC HETEROCYCLIC COMPOUND | 2009 |
|
RU2518073C2 |
| CONDENSING DICYCLIC NITROGEN CONTAINING HETEROCYCLES, WHICH HAVE DGAT INHIBITING ACTION | 2003 |
|
RU2342388C2 |
| CARBOSTYRIL COMPOUND | 2005 |
|
RU2430920C2 |
| INDOLIZINE DERIVATIVE AND ITS APPLICATION FOR MEDICAL PURPOSES | 2010 |
|
RU2529868C2 |
| 4-OXOQUINOLINE COMPOUND AND ITS USING AS HIV INTEGRASE INHIBITOR | 2003 |
|
RU2275361C2 |
| HETEROCYCLIC COMPOUND | 2017 |
|
RU2748693C2 |
